Profiling dynamic RNA–protein interactions using small-molecule-induced RNA editing
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ASAPbio crowd review)
Abstract
No abstract available
Article activity feed
-
-
Review coordinated via ASAPbio’s crowd preprint review
This review was completed by Ruchika Bajaj.
This study has developed a tool to characterize small molecule modulators of RNA-protein binding events. Please see below a few points which may help strengthen the manuscript.
- The term “temporal” is used multiple times in the paper, to facilitate clarity for readers from different disciplines, it may be useful to provide some further explanation or context for the term.
- Introduction section, “independent datasets have failed to reach consensus”, please provide some brief explanation about those independent datasets mentioned.
- Introduction section, last paragraph “We apply TRIBE ID to profile cytoplasmic G3BP1-RNA interactions …” - further explanation of these three processes linked together would be helpful.
- Figure 1, please provide some …
Review coordinated via ASAPbio’s crowd preprint review
This review was completed by Ruchika Bajaj.
This study has developed a tool to characterize small molecule modulators of RNA-protein binding events. Please see below a few points which may help strengthen the manuscript.
- The term “temporal” is used multiple times in the paper, to facilitate clarity for readers from different disciplines, it may be useful to provide some further explanation or context for the term.
- Introduction section, “independent datasets have failed to reach consensus”, please provide some brief explanation about those independent datasets mentioned.
- Introduction section, last paragraph “We apply TRIBE ID to profile cytoplasmic G3BP1-RNA interactions …” - further explanation of these three processes linked together would be helpful.
- Figure 1, please provide some further explanation for the difference between TRIBE and TRIBE-ID. Since the dimerization is forced by rapamycin, a control experiment to explain artifact binding would be helpful.
- In the section, “Rapamycin-mediated dimerization of G3BP1-FRB and FKBP-ADAR”, recommend adding some clarification about the goal of this experiment, which could be understanding either native processes or in a rapamycin-dependent manner.
- In section, “G3BP1 TRIBE analysis with human and Drosophila ADAR2 catalytic domains” - suggest commenting on the reasoning for ideal ADAR to possess characteristics like “high editing activity when dimerized or fused to G3BP1”. Are these characteristics important to increase signal/noise ratio in the assay? Also, an explanation of T375G mutation and control experiments with wild type ADAR for any inhibition effect for Figure 2 would be helpful.
- In the section, “Temporally controlled G3BP1-RNA interaction analysis with TRIBE-ID”, please clarify whether the experiment described in Figure 3 provides information about the time of interaction between RNA and G3BP1.
- A paragraph describing any limitations and other possible applications of this tool on other systems would add to the manuscript.
-
